Unknown NA INTERVENTIONAL 4-arm NCT01508637

Diesel Exhaust and Vascular Function (CVDTRAP4)

Effect of Diesel Exhaust Exposures on Vascular Function in Humans: The Role of Sympathetic Activation

Sponsor: Environmental Protection Agency (EPA)

Interventions Diesel Exhaust Filtered Air Terazosin placebo

Updated 6 times since 2017 Last updated: Jul 30, 2015 Started: Jan 31, 2012 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiovascular Effects and is currently ongoing. Environmental Protection Agency (EPA) leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Aug 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Environmental Protection Agency (EPA)
National Institute of Environmental Health Sciences (NIEHS)
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States